ER
Ernexa Therapeutics Inc. Warrants (ERNAW)
NASDAQ·Financial Services·Asset Management
$0.03
-1.54%
Mkt Cap $628.25K
Analyst Ratings
No recent rating data.
Price Target (28 analysts)
$236.90
Range $160.68 – $278.10
Implied Upside
+928919.6%
Consensus $236.90 vs current $0.03